Mesa Laboratories (NASDAQ:MLAB – Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, February 4th. Analysts expect Mesa Laboratories to post earnings of $1.41 per share and revenue of $58.83 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $1.81 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.14). Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%. The company had revenue of $57.83 million for the quarter, compared to analysts’ expectations of $58.60 million. On average, analysts expect Mesa Laboratories to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Mesa Laboratories Price Performance
Mesa Laboratories stock opened at $137.69 on Monday. Mesa Laboratories has a 52 week low of $83.68 and a 52 week high of $149.50. The firm has a market capitalization of $747.79 million, a PE ratio of -3.02 and a beta of 0.82. The company has a quick ratio of 0.51, a current ratio of 0.70 and a debt-to-equity ratio of 0.65. The firm’s 50-day simple moving average is $132.44 and its 200 day simple moving average is $125.18.
Mesa Laboratories Dividend Announcement
Analyst Ratings Changes
Separately, StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.
Read Our Latest Stock Analysis on MLAB
Mesa Laboratories Company Profile
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Featured Stories
- Five stocks we like better than Mesa Laboratories
- How is Compound Interest Calculated?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- What Are Growth Stocks and Investing in Them
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.